Intezer is a technology company.
Intezer provides a Forensic AI SOC solution that automates the triage, investigation, and response to security alerts, ensuring comprehensive coverage and fast, accurate results.
Intezer has raised $50.0M across 3 funding rounds.
Intezer has raised $50.0M in total across 3 funding rounds.
Intezer is a cybersecurity technology company specializing in genetic malware analysis, a unique approach that examines the "DNA" of software code to identify and classify both known and unknown malware strains. Its flagship product, Intezer Analyze, provides security teams with deep insights into cyber threats, enabling rapid identification, classification, and response. Intezer also offers Intezer Protect for real-time malware blocking and the Forensic AI SOC platform, which automates alert triage and incident response using AI and forensic-grade investigation techniques. The company serves enterprises, government agencies, and security operations centers (SOCs), addressing the critical problem of alert overload and cyber talent shortages by enhancing security team efficiency and accuracy[1][2][4][5].
Founded by cybersecurity experts with a vision to revolutionize malware detection, Intezer emerged from the insight that malware shares genetic code similarities akin to biological DNA. This idea led to the development of genetic malware analysis technology, which became the foundation of their flagship product. Early traction came from adoption by government agencies, intelligence organizations, and Fortune 500 companies, validating the approach and fueling growth. Over time, Intezer expanded its focus from malware analysis to full SOC automation with AI-driven triage and forensic investigation capabilities, evolving into a leader in the emerging AI SOC platform category[1][5][8].
Intezer rides the growing trend of AI-driven cybersecurity automation amid escalating cyber threats and a global shortage of skilled security professionals. The timing is critical as enterprises face overwhelming alert volumes and increasingly sophisticated malware, including fileless attacks and advanced persistent threats (APTs). Intezer’s genetic malware analysis and AI SOC automation address these market forces by enabling faster, more accurate threat detection and response, reducing false positives, and improving SOC productivity. Its technology influences the broader ecosystem by setting new standards for malware detection precision and operational efficiency in security operations[1][2][5][8].
Looking ahead, Intezer is positioned to deepen its impact by expanding AI capabilities, enhancing forensic investigation tools, and broadening integrations across security platforms. Trends such as increased cloud adoption, AI advancements, and evolving threat landscapes will shape its journey. Intezer’s influence is likely to grow as organizations demand more autonomous, intelligent security solutions to keep pace with cyber threats. Its unique genetic malware approach combined with AI-driven SOC automation offers a compelling vision for the future of cybersecurity, where rapid, accurate, and scalable defense becomes the norm[4][5][9].
Intezer has raised $50.0M in total across 3 funding rounds.
Intezer's investors include Battery Ventures, Matias Ventures, Norwest Venture Partners, Openview Venture Partners, Alon N. Cohen.
Intezer has raised $50.0M across 3 funding rounds. Most recently, it raised $33.0M Series C in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $33.0M Series C | Battery Ventures, Matias Ventures, Norwest Venture Partners, Openview Venture Partners, Alon N. Cohen | |
| Jan 1, 2020 | $15.0M Series B | Norwest Venture Partners, Openview Venture Partners, Alon N. Cohen | |
| Dec 1, 2016 | $2.0M Seed | Norwest Venture Partners, Openview Venture Partners |